Lixte Biotechnology (LIXT) Institutional Ownership $1.27 -0.09 (-6.61%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$1.27 0.00 (-0.01%) As of 02/21/2025 06:19 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Lixte Biotechnology (NASDAQ:LIXT)CurrentInstitutional OwnershipPercentage5.10%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$232.52KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$65.81K Get LIXT Insider Trade Alerts Want to know when executives and insiders are buying or selling Lixte Biotechnology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data LIXT Institutional Buying and Selling by Quarter Lixte Biotechnology Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/11/2025 TIAA Trust National Association101,834$207K0.0%N/A4.526% 1/31/2025 Atlas Legacy Advisors LLC12,707$26K0.0%N/A0.565% 1/13/2025 FNY Investment Advisers LLC39,219$82K0.0%-45.3%1.744% 6/5/2023 EP Wealth Advisors LLC2,211$786K0.0%N/A0.013% 2/9/2023 Ethos Financial Group LLC248,084$126K0.0%N/A1.490% 8/12/2022 Almanack Investment Partners LLC.248,084$185K0.0%-66.7%1.490% 11/9/2021BlackRock Inc.13,425$28K0.0%+191.9%0.098% 11/4/2021 Almanack Investment Partners LLC.806,050$1.68M0.1%-17.9%5.863% 8/16/2021 State Street Corp33,600$102K0.0%N/A0.244% 8/16/2021 Sabby Management LLC65,511$199K0.0%-17.8%0.477% 8/13/2021 Renaissance Technologies LLC50,900$154K0.0%N/A0.370% 8/13/2021 Vanguard Group Inc.74,383$225K0.0%N/A0.544% 8/4/2021 Almanack Investment Partners LLC.982,046$2.98M0.3%-5.8%7.189% 5/21/2021 Citadel Advisors LLC23,813$79K0.0%N/A0.174% 5/18/2021 Citadel Advisors LLC23,813$79K0.0%N/A0.174% 5/11/2021 Almanack Investment Partners LLC.1,042,105$3.43M0.3%N/A7.698% 2/16/2021 Santa Monica Partners LP166,667$528K0.4%N/A1.347% (Data available from 1/1/2016 forward) LIXT Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of LIXT shares? During the previous two years, the following institutional investors and hedge funds held shares of Lixte Biotechnology shares: EP Wealth Advisors LLC ($786K), TIAA Trust National Association ($207K), and FNY Investment Advisers LLC ($82K), Atlas Legacy Advisors LLC ($26K).Learn more on LIXT's institutional investors. What percentage of Lixte Biotechnology stock is owned by institutional investors? 5.10% of Lixte Biotechnology stock is owned by institutional investors. Learn more on LIXT's institutional investor holdings. Which institutional investors have been buying Lixte Biotechnology stock? The following institutional investors have purchased Lixte Biotechnology stock in the last 24 months: TIAA Trust National Association ($101.83K), Atlas Legacy Advisors LLC ($12.71K), and EP Wealth Advisors LLC ($2.21K). How much institutional buying is happening at Lixte Biotechnology? Institutional investors have bought a total of 116,752 shares in the last 24 months. This purchase volume represents approximately $250.81K in transactions. Which Lixte Biotechnology major shareholders have been selling company stock? The following institutional investors have sold Lixte Biotechnology stock in the last 24 months: FNY Investment Advisers LLC ($32.42K). How much institutional selling is happening at Lixte Biotechnology? Institutional investors have sold a total of 32,419 shares in the last 24 months. This volume of shares sold represents approximately $65.81K in transactions. Related Companies INAB Major Shareholders APRE Major Shareholders OKUR Major Shareholders SNTI Major Shareholders MIRA Major Shareholders LPCN Major Shareholders BCAB Major Shareholders MEIP Major Shareholders MRKR Major Shareholders CARM Major Shareholders This page (NASDAQ:LIXT) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredWarning: China Launches AI Attack on AmericaIf you have any money in AI stocks, pay attention because... According to Louis Navellier, the legendary in...InvestorPlace | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lixte Biotechnology Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lixte Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
